Skip to main content
# Title Department Research Year
61 New 1, 2, 4‐oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity Department of Pharmaceutical Organic Chemistry 2022
62 Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties Department of Pharmaceutical Organic Chemistry 2022
63 Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 complex from SARS-CoV-2. 2022
64 A Novel C Fe Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma Department of Industrial Pharmacy 2022
65 Microwave-Assisted Synthesis, Biological Activity Evaluation, Molecular Docking, and ADMET Studies of Some Novel Pyrrolo [2,3-b] Pyrrole Derivatives Department of Medicinal Chemistry 2022
66 Elegant, Flexible Vesicular Nanocarriers for the Efficient Skin Delivery of Topically Applied Drugs Department of Pharmaceutics 2022
67 Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAFV600E 2022
68 Nanocomposite of gold nanoparticles@nickel disulfide-plant derived carbon for molecularly imprinted electrochemical determination of favipiravir Department of Pharmaceutical Analytical Chemistry 2022
69 THE INHIBITORY EFFECT OF DOUM PALM (HYPHAENE THEBAICA L. MART.) LEAVES EXTRACT ON α-GLUCOSIDASE ACTIVITY Department of Pharmacognosy 2022
70 Celecoxib-Loaded Solid Lipid Nanoparticles for Colon Delivery: Formulation Optimization and In Vitro Assessment of Anti-Cancer Activity 2022